See Wegovy savings for more.
Reducing Dementia Risk Factors Semaglutide improves key risk factors linked to dementia, including: Blood sugar control Insulin resistance Obesity Cardiovascular health Interestingly, some studies found reduced dementia risk even in people without obesity, suggesting that semaglutides effects may extend beyond weight loss alone
As a result, many patients experience: Reduced appetite Improved satiety Better metabolic regulation Gradual, sustainable weight loss Semaglutide and tirzepatide are two of the most widely discussed medications in this category
While its not clear whether the medication itself directly increases fertility, it does help regulate menstrual cycles by addressing underlying health issues like obesity
There is also evidence suggesting that semaglutide induces the expression of Glut-4 [57]
By promoting vasodilation and reducing fluid volume through natriuresis, semaglutide helps regulate blood pressure, making it a potentially valuable treatment option for individuals with hypertension